Fortis Healthcare Limited, headquartered in Gurgaon, India, is a leading integrated healthcare provider operating 27 hospitals with over 4,700 beds and 426 diagnostics centers across India, UAE, Nepal, and Sri Lanka. Listed on BSE and NSE, it is majority-owned by Malaysia’s IHH Healthcare. Fortis generates revenue of ₹1,928 crore (US$221 million) in Q3 FY25, with hospital business contributing 80% of EBITDA and diagnostics 20%. Under CEO Dr. Ashutosh Raghuvanshi, Fortis has focused on portfolio rationalization, exiting loss-making Chennai facilities, and pursuing brownfield expansions, adding 1,800 beds by FY28, particularly in Delhi NCR and Punjab. Oncology, contributing ~13% to revenue, is a fast-growing segment. With a net debt-to-equity ratio of 0.04x and 19.8% hospital revenue growth in FY23, Fortis targets 10% annual organic growth through tech investments and M&A, capitalizing on India’s underserved healthcare market while navigating competitive valuations and regulatory pressures.

Latest News on Fortis Healthcare

The Supreme Court has issued a notice to Fortis Hospital and other parties in response to a petition seeking compensation for a brain injury.

The Supreme Court of India has issued a notice to Fortis Hospital in response to a plea filed by an 8-year-old child, Devarsh Jain, seeking compensation of Rs 1350 crore for an alleged brain injury at birth in 2017. The child, who is in a vegetative state, approached the court through his mother, alleging that two pediatricians employed by the hospital caused him severe brain damage due to their reckless handling. The damage has resulted in the child suffering from cerebral palsy, epilepsy, and severe visual impairment, leaving him mute and unresponsive.

The appeal was filed against the National Consumer Dispute Redressal Commission (NCDRC), which dismissed the original complaint in March 2025. The NCDRC’s decision was challenged by the child’s mother, who argued that the commission had misconstrued the facts of the complaint and treated it as a public interest litigation against the entire medical industry. The Supreme Court has listed the matter for further hearing on December 8, 2025.

The child’s lawyers, senior advocate Menaka Guruswamy and advocate Rajiv Ranjan Dwivedi, argued that the two pediatricians responsible for the child’s care were unqualified and had been appointed to senior positions in the hospital’s Neonatal Intensive Care Unit (NICU). They alleged that the doctors’ mishandling of the child had caused irreversible brain damage, resulting in a permanent vegetative state.

Fortis Hospital has responded to the allegations, stating that it has not yet been served with a notice from the Supreme Court and will review the allegations and issue a formal response once the relevant documents and legal filings are received. The hospital has retained its rights to review the allegations and will respond in accordance with the law.

The case highlights the issue of medical negligence and the need for accountability in the healthcare sector. The Supreme Court’s decision to issue a notice to Fortis Hospital is a significant development in the case, and the outcome of the hearing on December 8, 2025, will be closely watched. The child’s family is seeking compensation for the alleged negligence, which they claim has resulted in a lifetime of suffering and disability for the child.

Fortis’ S.L. Raheja Hospital achieves a significant milestone in cancer treatment with its first successful bone marrow transplant procedure.

S.L. Raheja Hospital, Mahim – A Fortis Associate, has successfully completed its first-ever Bone Marrow Transplant (BMT) at the Center of Excellence (COE) for Haemato-Oncology. The transplant was performed on a 61-year-old patient, Bijayentimala Devi, from Manipur, who was diagnosed with Multiple Myeloma, a complex form of blood cancer. The patient underwent an autologous stem cell transplant, which has led to a significant improvement in her health, weight gain, and overall well-being.

The transplant was led by a team of Haemato-Oncologists and Bone Marrow Transplant specialists, including Dr. Abhay Bhave, Dr. Shreya Agrawal, and Dr. Shrinath Kshirsagar. The team is supported by a multidisciplinary clinical team and a state-of-the-art BMT department equipped with advanced infection-control systems, precision monitoring, and specialized post-transplant care facilities.

According to Dr. Kunal Punamiya, CEO of S.L. Raheja Hospital, this transplant marks a significant milestone in the hospital’s pursuit of medical excellence. The clinical team noted that a Bone Marrow Transplant often represents the best chance at long-term survival for patients with multiple myeloma and other critical blood disorders.

The patient’s husband, Mr. Khamba, expressed his gratitude for the care and support they received at the hospital. He stated that the medical team provided exceptional care, both physically and emotionally, and that the improvements they’ve seen have been remarkable.

The successful completion of the Bone Marrow Transplant is a testament to S.L. Raheja Hospital’s commitment to innovation, excellence, and holistic healing. The hospital continues to expand its expertise across oncology, neurology, and transplant medicine, empowering patients with access to world-class treatment options that redefine recovery and resilience.

The patient has fully recovered and been discharged from the hospital, just in time to celebrate Diwali with her loved ones, symbolizing the triumph of light over darkness and marking the start of a new life filled with hope and healing. This achievement underscores the hospital’s ability to deliver advanced, life-saving therapies with empathy and precision, creating extraordinary patient outcomes.

ICICI Securities has identified Apollo Hospitals and Metropolis as top choices in the healthcare sector, ahead of the release of Q2 results.

ICICI Securities has released its top picks in the healthcare sector, with Apollo Hospitals and Metropolis being the favored choices. This comes ahead of the Q2 results, which are expected to be released soon.

The brokerage firm has maintained a “buy” rating on Apollo Hospitals, citing the company’s strong performance in the previous quarter. Apollo Hospitals has been a consistent performer, with a robust growth in its healthcare services segment. The company’s expansion plans, including the addition of new hospitals and diagnostic centers, are expected to drive growth in the coming quarters.

Metropolis, a leading diagnostic chain, has also been endorsed by ICICI Securities. The firm has predicted a strong Q2 performance for Metropolis, driven by a rise in diagnostic volumes and a stable operating margin. Metropolis has been expanding its presence across the country, with a focus on increasing its reach in tier-2 and tier-3 cities.

Other healthcare companies that are expected to perform well in Q2 include Fortis Healthcare, Narayana Hrudayalaya, and Dr. Lal PathLabs. These companies have been investing heavily in expansion and modernization, which is expected to yield positive results in the coming quarters.

The Q2 results are expected to be influenced by several factors, including the ongoing COVID-19 pandemic, changes in government policies, and the increasing demand for healthcare services. The healthcare sector has been one of the most resilient sectors during the pandemic, with companies adapting quickly to the changing circumstances.

ICICI Securities has predicted a strong Q2 performance for the healthcare sector, driven by a rise in hospitalization rates, increased diagnostic volumes, and a stable operating margin. The firm has also highlighted the importance of digital transformation in the healthcare sector, with companies investing heavily in telemedicine, artificial intelligence, and data analytics.

Overall, the Q2 results are expected to be positive for the healthcare sector, with Apollo Hospitals and Metropolis being the top picks. The sector’s resilience and adaptability during the pandemic have made it an attractive investment opportunity, with several companies poised for strong growth in the coming quarters. As the healthcare sector continues to evolve, it will be interesting to see how companies adapt to the changing landscape and capitalize on emerging trends.

Statement released by Fortis Mohali regarding the health status of Punjabi singer Rajvir Jawanda.

Fortis Hospital in Mohali has issued a statement regarding the condition of Punjabi singer Rajvir Jawanda, who was admitted to the hospital after being shot in the United States. According to the statement, Jawanda is currently undergoing treatment at the hospital and his condition is being closely monitored by a team of doctors.

The hospital stated that Jawanda was admitted to the emergency department with gunshot wounds and was immediately taken into surgery. The surgical team worked to repair the damage and stabilize his condition. After the surgery, Jawanda was shifted to the intensive care unit (ICU) for further treatment and observation.

The hospital’s statement revealed that Jawanda’s condition is critical but stable. He is being treated by a team of specialists, including surgeons, intensivists, and other medical professionals. The hospital is providing him with the best possible care and treatment, and his family is being kept informed about his condition.

The statement also requested that Jawanda’s fans and well-wishers respect the family’s privacy during this difficult time. The hospital has appealed to everyone to refrain from spreading rumors or speculation about Jawanda’s condition, as this can cause unnecessary distress to the family.

Rajvir Jawanda is a popular Punjabi singer known for his hit songs such as “Kangni” and “Sardarni”. He has a huge following in Punjab and among Punjabi music fans worldwide. The news of his shooting has sent shockwaves in the music industry, and fans are praying for his speedy recovery.

The incident has also raised concerns about the safety and security of Indian artists living and working abroad. The Indian government and authorities are likely to take up the matter with the US authorities to ensure that a thorough investigation is conducted and the perpetrators are brought to justice.

As Jawanda continues to receive treatment at Fortis Hospital, his fans and well-wishers are hoping for his speedy recovery. The hospital’s statement has provided some reassurance, but the road to recovery is likely to be long and challenging. Jawanda’s family and fans are keeping their fingers crossed, praying that he will overcome this difficult phase and return to his music and fans soon.

Fortis in India plans to increase the number of its obesity clinics due to a surge in demand for weight-loss treatments, according to the company’s CEO.

India’s Fortis Healthcare is planning to expand its obesity clinics across the country, according to its CEO. The move comes as the demand for weight-loss therapies is on the rise. The company aims to capitalize on the growing trend of people seeking medical help to manage their weight.

The CEO stated that the number of people opting for weight-loss surgeries and other obesity-related treatments has increased significantly over the past few years. This growth is driven by rising awareness about the health risks associated with obesity, such as diabetes, heart disease, and other lifestyle-related disorders.

Fortis Healthcare currently operates a few obesity clinics in major cities like Delhi and Mumbai. However, the company plans to expand its network to other cities and towns, where the demand for such services is increasing. The CEO believes that the market for weight-loss therapies is still largely untapped in India, and Fortis is well-positioned to take advantage of this opportunity.

The expansion plans include setting up new clinics, hiring more doctors and staff, and investing in advanced medical equipment. The company will also offer a range of services, including weight-loss surgeries, diet counseling, and other non-surgical treatments.

The growing demand for weight-loss therapies in India is driven by changing lifestyles, increased awareness about health risks, and a growing middle class with disposable income. According to estimates, India has over 30 million obese people, and this number is expected to rise in the coming years.

Fortis Healthcare’s expansion plans are likely to be welcome news for people struggling with obesity. The company’s clinics will provide access to specialized medical care, which is currently limited in many parts of the country. By expanding its services, Fortis aims to help people manage their weight and reduce the risk of obesity-related health problems.

The CEO emphasized that the company’s goal is to provide high-quality, patient-centric care to people struggling with obesity. With its expansion plans, Fortis Healthcare is poised to become a leading player in India’s growing weight-loss therapy market. As the demand for such services continues to rise, the company is well-positioned to capitalize on this trend and make a positive impact on public health.

Stock Market Updates for Fortis Healthcare

Recent Updates

Fortis introduces specialized orthopaedic and sports injury outpatient department in Srinagar

Fortis Healthcare has launched a monthly Orthopaedics and Sports Injury Outpatient Department (OPD) in Srinagar, aimed at providing specialized musculoskeletal and sports medicine care to residents. The OPD will be led by Dr. Tapish Shukla, an Associate Consultant in Orthopaedics and Sports Injury at Fortis Escorts Amritsar. It will operate on the fourth Wednesday of every month from 11:00 am to 2:00 pm at Syed Health Zone in Karan Nagar, starting from September 8, 2025.

The OPD will offer consultations for a range of conditions, including sports injuries, joint pain, ACL tears, ligament injuries, meniscus repairs, arthroscopy, and other advanced orthopaedic surgeries. This initiative is part of Fortis Healthcare’s commitment to bridging the gap in healthcare between major cities and regions with limited access to specialized care. By providing localized access to specialized care, Fortis aims to reduce the need for patients to travel long distances, thereby decreasing travel costs and physical strain.

According to Dr. Shukla, this initiative will make a significant difference in patient outcomes and quality of life. By bringing specialized care closer to residents, Fortis Healthcare hopes to improve the overall healthcare experience for patients in Srinagar. The launch of the OPD is a positive step towards expanding access to specialized healthcare services in the region.

The introduction of the monthly OPD is expected to benefit patients who require specialized orthopaedic care. With the presence of a leading healthcare chain like Fortis, patients in Srinagar will now have access to high-quality care without having to travel to larger cities. This is likely to lead to improved patient outcomes, reduced healthcare costs, and a better quality of life for residents in the region. Overall, the launch of the Orthopaedics and Sports Injury OPD in Srinagar is a significant development in the region’s healthcare landscape.

Hospitals are experiencing a significant change in their revenue streams, with oncology emerging as the most lucrative department.

India’s top hospital chains, including Max Healthcare, Apollo Hospitals, and Fortis Healthcare, are experiencing a significant shift in their revenue mix, with oncology emerging as the fastest-growing and most profitable specialty. Oncology, once a niche segment, is now a central part of their strategic plans, driven by rising cancer incidence, improved diagnostics, and high-complexity treatments that command premium pricing.

At Max Healthcare, oncology contributes nearly 25% of inpatient revenue, making it the largest therapeutic segment. Fortis Healthcare reported a 28% year-on-year growth in oncology revenue in Q1 FY26, with the segment accounting for 16.4% of total hospital income. Apollo Hospitals, which pioneered proton therapy in India, sees oncology as both a clinical and commercial imperative, operating 13 Comprehensive Cancer Centres across 12 cities.

The growth in oncology is underpinned by factors such as rising cancer incidence, improved screening, insurance penetration, and the inherently high revenue per patient. Cancer care typically involves multidisciplinary teams, advanced diagnostics, and long treatment cycles, making it a high-margin specialty. According to the National Cancer Registry Programme Report 2020, the number of cancer cases in 2020 was estimated to be 13.9 lakhs, and it is projected to increase to 15.7 lakhs by 2025.

Hospitals are investing heavily in infrastructure, including expensive radiation therapy, robotic surgery machines, and advanced diagnostics. The demand for oncology services is strong, with LINAC utilization rising to 69% at HCG, reflecting the growing need for cancer care. As insurance penetration improves, more patients can afford advanced oncology procedures, further fueling demand.

The convergence of clinical need and commercial opportunity is making oncology the centerpiece of growth strategies for India’s leading hospital chains. With its high revenue potential and growing demand, oncology is expected to continue driving growth for these hospitals in the coming years. As Abhay Soi, Chairman and MD of Max Healthcare, said, “Oncology clearly is growing faster for us,” and hospitals are making significant investments in radiation oncology infrastructure to meet the growing demand.

Punjab’s Chief Minister is exhibiting signs of improvement while being closely monitored at Fortis Hospital.

Punjab Chief Minister Bhagwant Mann was admitted to Fortis Hospital in Mohali on Friday evening due to exhaustion and a low heart rate. The 51-year-old leader has been showing improvement, with stable vital signs and gradually improving blood parameters, according to hospital authorities. Mann was visited by several senior Aam Aadmi Party (AAP) leaders and Punjab cabinet ministers, including Manish Sisodia, Harpal Singh Cheema, Aman Arora, Gurmeet Singh Khuddian, and Sanjeev Arora.

Sisodia, who met with Mann, stated that the Chief Minister had been unwell for the past 2-3 days due to an electrolyte imbalance. However, he assured that Mann is currently fine and there is nothing to worry about. According to Sisodia, the doctors predict that Mann will remain in the hospital for one or two more days. The meeting of the Punjab cabinet, which was scheduled to be chaired by Mann, was postponed on Friday due to his illness.

Mann was also unable to accompany AAP national convener Arvind Kejriwal on a visit to flood-affected areas on Thursday. Kejriwal visited Mann at his official residence on Thursday to enquire about his health. This is not the first time Mann has been treated at Fortis Hospital, as he was admitted about a year ago for a bacterial infection.

The hospital authorities continue to monitor Mann’s condition, and his improvement is a positive sign. The visit from senior AAP leaders and cabinet ministers demonstrates the concern and support for the Chief Minister’s health. With Sisodia’s assurance that Mann is fine and will likely be discharged in a few days, it appears that the situation is under control. However, the exact nature of Mann’s illness and the expected duration of his hospital stay remain uncertain. As the situation develops, further updates on the Chief Minister’s health are expected to be released.

Punjab Chief Minister Bhagwant Mann’s condition worsens, hospitalized at Fortis Mohali

Punjab Chief Minister Bhagwant Mann has been admitted to Fortis Hospital in Mohali due to health concerns. According to reports, Mann complained of exhaustion and a low heart rate, prompting his hospitalization. The news has led to the postponement of a scheduled Cabinet meeting to discuss the ongoing flood situation in the state.

Mann’s health issues have raised concerns, and he is currently undergoing treatment at the hospital. The exact nature of his condition is not yet clear, but his symptoms suggest that he may be experiencing fatigue and cardiovascular issues. The hospitalization has also led to changes in the schedule of other political events, including a visit by Delhi Chief Minister Arvind Kejriwal to flood-affected areas in Punjab.

Kejriwal, who is also the national convener of the Aam Aadmi Party (AAP), toured the flood-hit regions of Punjab, assessing the damage and meeting with affected residents. However, Mann was unable to accompany him due to his health issues. The AAP leader’s visit was seen as an attempt to show solidarity with the people of Punjab and to highlight the need for relief efforts.

The flood situation in Punjab remains a major concern, with many areas still underwater and thousands of people displaced. The state government has been working to provide relief and rehabilitation to those affected, but the task is daunting. The postponement of the Cabinet meeting has delayed discussions on the flood situation, and it is unclear when the meeting will be rescheduled.

Mann’s health issues have added to the challenges facing the Punjab government, which is already dealing with the aftermath of the floods. The hospitalization of the Chief Minister has raised concerns about the stability of the government and the impact on its ability to respond to the flood crisis. As the situation continues to unfold, it remains to be seen how the government will address the challenges ahead and provide relief to those affected by the floods.

Fortis Hospital in Mohali hosts the zonal finals of ‘PSYCH-ED 2025’

Fortis Hospital, Mohali, recently hosted the zonal finals of the 8th edition of its national psychology quiz program, “PSYCH-ED, 2025”. The event saw participation from over 900 schools across India, with more than 12,000 students from 190+ cities taking part in the online round. The quiz was designed for students in classes XI and XII, aiming to test their knowledge of psychology and its concepts. The program was supported by several organizations, including GD Goenka University, Project CACA, Rupa Publications, and Adayu, a Fortis group company.

The quiz has grown into a flagship national-level event, engaging schools from urban metros, small towns, and even overseas, creating an inclusive platform for learning and discussion. The objective of the quiz is to impart learning while making the discipline of psychology engaging and fun for students. According to Dr. Samir Parikh, Chairperson, Fortis National Mental Health Programme, the initiative aims to promote awareness, reduce stigma around mental health, and inspire curiosity about psychology among school students.

The winning team from Bal Bharti School, Ludhiana, consisting of Anaisha Sharma, Prabhdeep Kaur, and Tanya Singla, will move on to the national finals in Delhi. The team expressed their excitement and gratitude towards their psychology teacher, who helped them prepare for the quiz. The quiz serves as an engaging and enjoyable way to learn, blending education with fun. The program has been conceptualized and executed under the aegis of Dr. Parikh, who believes that initiatives like PSYCH-ED can help promote awareness and reduce stigma around mental health.

The success of PSYCH-ED 2025 demonstrates the growing interest in psychology among school students, and the need for such initiatives to promote awareness and education about mental health. With its inclusive platform and engaging format, PSYCH-ED has become a unique and valuable resource for students, teachers, and schools across India. As the program continues to grow and evolve, it is likely to have a positive impact on the way psychology is perceived and studied in Indian schools, and contribute to a greater understanding and awareness of mental health issues.

Fortis acquires Shrimann hospital in a massive Rs 462 crore deal

Fortis Healthcare has expanded its presence in Punjab by acquiring the 228-bed Shrimann Superspecialty Hospital for a consideration of Rs 462 crore. This marks the fifth hospital of Fortis in Punjab, with existing hospitals in Ludhiana, Mohali, and Amritsar. The acquired hospital is located on the Pathankot road and is built on a 3-acre land parcel. Fortis plans to expand the hospital’s capacity by adding 225 more beds, utilizing an adjacent 2.4-acre land chunk, taking the total bed count to over 450.

The hospital currently has a staff of 65 doctors and 1,000 support staff, which Fortis aims to retain while adding more specialists to the existing team. The medical charges for treatment will remain the same, ensuring continuity for patients. The hospital already has 25 specialty departments, including cardiac sciences, renal sciences, general and laparoscopic surgery, oncology, orthopaedics, neurosciences, and gastroenterology.

The hospital is equipped with advanced technologies such as PET Scan, fibroscan, and 28 dialysis beds, along with four advanced Operation Theatres and a Cath Lab. Fortis plans to add more advanced technologies to enhance patient care. The hospital is already empaneled with prominent government agencies, including the Ex-Servicemen Contributory Health Scheme (ECHS), Central Government Health Scheme (CGHS), Northern Railways, and the Central Armed Police Forces.

The promoters of Shrimann Hospital, Dr. V P Sharma, Dr. Harmeet Paul Singh, Dr. Rajeev Bhatia, and Dr. Ajay Marwaha, have welcomed the Fortis team, believing that the corporate environment will boost patient-centric care and infrastructural needs. The complete takeover process is expected to be completed within two months, as stated by Ashish Bhatia, Executive Vice-President of Fortis Healthcare. With this acquisition, Fortis Healthcare strengthens its presence in Punjab, providing high-quality healthcare services to a wider population.

Fortis Hospital ordered to compensate Rs 50 lakh for medical negligence

The District Consumer Disputes Redressal Commission in Chandigarh has held Fortis Hospital in Mohali and one of its doctors guilty of medical negligence. The commission has ordered the hospital to pay a compensation of Rs 50 lakh along with 9% interest per annum to the widow of a patient who died during treatment. The patient, Harit Sharma, was admitted to the hospital in 2021 with an acute gastric problem. Despite initial improvement, his condition deteriorated due to alleged negligence in a medical procedure called tapping, which was done to remove ascites from his stomach.

The patient’s wife, Priyanka Sharma, filed a complaint with the commission, alleging that the hospital staff was negligent in performing the tapping procedure, which led to a drastic drop in her husband’s oxygen levels. She claimed that her husband was fully conscious and aware of the mistake made by the hospital staff, and he even wrote a note to her conveying what had happened during the procedure. Unfortunately, Harit Sharma passed away on August 2, 2021.

The hospital authorities refuted the allegations, claiming that there was no negligence on their part and that there was no expert evidence to prove otherwise. However, the commission found the hospital liable for medical negligence, deficiency in service, and unfair trade practice. The commission ordered the hospital to pay a lump sum compensation of Rs 50 lakh along with 9% interest per annum from the date of the patient’s death.

The commission’s decision was based on the fact that the hospital had failed to provide adequate care and treatment to the patient, leading to his death. The commission also took into account the dying declaration made by the patient, which provided evidence of the hospital’s negligence. The order highlights the importance of hospitals and medical professionals providing adequate care and treatment to patients, and the consequences of failing to do so. The case serves as a reminder of the need for accountability and transparency in the medical profession.

Fortis and Agilus Enhance Genomic Testing Capabilities with Additional Genexus System, Accelerating Cancer Diagnosis.

Fortis and Agilus have partnered to enhance genomic testing capabilities with the installation of a second Genexus system. This move is expected to significantly improve the speed and accuracy of cancer diagnosis. The Genexus system is a next-generation sequencing (NGS) platform that enables comprehensive genomic profiling, allowing for the analysis of multiple genes and biomarkers in a single test.

The addition of a second Genexus system will increase Fortis’s testing capacity, enabling the processing of a higher volume of samples and reducing turnaround times. This is particularly crucial in cancer diagnosis, where timely and accurate results are essential for guiding treatment decisions. With the enhanced capacity, Fortis and Agilus aim to provide faster and more accurate diagnosis, ultimately improving patient outcomes.

The Genexus system offers several advantages, including its ability to analyze multiple genes and biomarkers simultaneously, reducing the need for multiple tests and minimizing tissue requirements. This comprehensive approach enables the identification of genetic mutations and variations that can inform treatment strategies, including targeted therapies and immunotherapies.

The partnership between Fortis and Agilus is built on a shared commitment to improving cancer diagnosis and treatment. Agilus, a leading provider of genetic testing solutions, has developed the Genexus system to address the growing need for advanced genomic testing. Fortis, a prominent healthcare provider, has recognized the potential of the Genexus system to enhance its diagnostic capabilities and has invested in the technology to improve patient care.

The installation of the second Genexus system is a significant milestone in the partnership between Fortis and Agilus. It demonstrates their shared commitment to leveraging cutting-edge technology to improve cancer diagnosis and treatment. With the enhanced genomic testing capabilities, Fortis and Agilus are poised to make a meaningful impact on patient care, enabling faster and more accurate diagnosis, and ultimately improving treatment outcomes.

In conclusion, the partnership between Fortis and Agilus has resulted in the installation of a second Genexus system, strengthening their genomic testing capabilities and enabling faster cancer diagnosis. The enhanced capacity and accuracy of the Genexus system will have a significant impact on patient care, providing timely and accurate results that can inform treatment decisions. As the demand for advanced genomic testing continues to grow, the collaboration between Fortis and Agilus is well-positioned to drive innovation and improve patient outcomes in the field of cancer diagnosis and treatment.

Fortis Hospital, Manesar Achieves Breakthrough in Treating 38-Year-Old Stage 4 Head and Neck Cancer Patient with Innovative Targeted Oral Therapy

A 38-year-old man diagnosed with stage 4 head and neck cancer has successfully undergone treatment at Fortis Hospital, Manesar, using targeted oral therapy. The patient, who was initially diagnosed with a tumor in his throat, had been experiencing symptoms such as difficulty swallowing and breathing. Upon further examination, the tumor was found to have spread to his lymph nodes, indicating an advanced stage of cancer.

The medical team at Fortis Hospital, led by Dr. Anil Mandrol, Consultant, Medical Oncology, decided to treat the patient using targeted oral therapy. This approach involves the use of oral medications that specifically target the cancer cells, reducing the harm to healthy cells. The therapy was tailored to the patient’s specific genetic profile, which was determined through advanced genetic testing.

The treatment consisted of a combination of oral medications, including a tyrosine kinase inhibitor, which helps to block the growth of cancer cells. The patient was also given supportive care to manage any side effects of the treatment. The medical team closely monitored the patient’s progress, adjusting the treatment plan as needed.

After several months of treatment, the patient showed significant improvement, with the tumor shrinking by over 70%. The patient’s symptoms also improved, and he was able to swallow and breathe more easily. The treatment was well-tolerated, with minimal side effects.

The success of the treatment is attributed to the targeted approach, which allowed the medical team to specifically target the cancer cells while minimizing harm to healthy cells. The use of advanced genetic testing also played a crucial role in determining the most effective treatment plan for the patient.

Dr. Mandrol noted that the case highlights the importance of personalized medicine in cancer treatment. “Targeted therapy has revolutionized the way we treat cancer,” he said. “By tailoring the treatment to the individual patient’s genetic profile, we can achieve better outcomes and improve the quality of life for our patients.”

The patient is now in remission, and his quality of life has significantly improved. The case serves as an example of the effectiveness of targeted oral therapy in treating advanced head and neck cancer, and highlights the importance of personalized medicine in cancer treatment. The medical team at Fortis Hospital, Manesar, continues to provide comprehensive care to patients with cancer, using the latest advancements in medical technology and treatment approaches.

On World Kidney Cancer Day, physicians at Mohali’s Fortis Hospital launch an initiative to educate the public about the causes and symptoms of kidney cancer.

On June 19, World Kidney Cancer Day, doctors at Fortis Hospital in Mohali are raising awareness about the increasing incidence of kidney cancer in India. They are highlighting the symptoms of the disease, which include abdominal pain, swelling in the abdomen, unexplained weight loss, and blood in urine. Kidney cancer, also known as renal cancer, is a chronic disease that originates in the kidneys when cells grow out of control. The global theme for this year’s World Kidney Cancer Day is “Show Your Kidneys Some Love,” which aims to encourage people to take care of their kidneys.

Dr. Dharmender Aggarwal, a consultant in uro-oncology and robotic surgery, shared a health advisory to shed light on kidney cancer, its causes, warning signs, and prevention. According to him, the main causes of kidney cancer are smoking, obesity, poor diet, high blood pressure, long-term kidney dialysis, exposure to chemicals, and hereditary factors. The warning signs of kidney cancer include blood in urine, abdominal pain and swelling, lump in the abdomen, constant tiredness, unexplained weight loss, and fever not caused by cold or flu.

The main treatment for kidney cancer is surgery, which may be partial or radical nephrectomy. In partial nephrectomy, the surgeon removes the tumor-affected part of the kidney, while in radical nephrectomy, the entire kidney is removed. Dr. Aggarwal emphasized that while kidney cancer cannot be prevented, the risk of contracting the disease can be lowered by abstaining from smoking, controlling hypertension, getting regular ultrasounds, and maintaining a healthy weight.

He also stressed the importance of early detection and treatment, which can improve the chances of survival. By raising awareness about kidney cancer and its symptoms, doctors hope to encourage people to take preventive measures and seek medical attention if they experience any unusual symptoms. By showing love and care to our kidneys, we can reduce the risk of kidney cancer and maintain overall health and well-being. As the world observes World Kidney Cancer Day, it is essential to prioritize kidney health and take proactive steps to prevent this chronic disease.

Manipal and Fortis are engaging in discussions to secure Rs 5,000 crore for a potential acquisition of Sahyadri Hospitals.

The bidding process for Sahyadri Hospitals, a multispecialty hospital chain, is nearing its deadline of June 22. Interested bidders, including Manipal Health Enterprises and Fortis Healthcare, are in talks with foreign lenders to secure financing of up to Rs 5,000 crore to support their bids. The hospital chain, which operates 11 hospitals with 1,300 beds across Maharashtra, is being sold by Ontario Teachers’ Pension Plan (OTPP), which acquired a 98.9% stake in the company less than three years ago.

Manipal and Fortis are engaging with global banks such as DBS Group Holdings, Deutsche Bank AG, Mizuho Bank, HSBC Holdings, and Barclays to raise the necessary funds. Another potential bidder, Aster DM Healthcare, has yet to finalize its financing discussions. The acquisition of Sahyadri Hospitals is expected to be a significant deal in the Indian hospital sector, which has seen consolidation in recent times.

OTPP, which has over $3 billion invested in India, hired Jefferies to run the sale process earlier this year. The Canadian pension fund had acquired Sahyadri Hospitals from Everstone Capital at a valuation of Rs 2,500 crore. The hospital chain has a strong presence in Maharashtra, with facilities covering specialties such as cardiology, transplants, neurology, and critical care.

The bidding for Sahyadri Hospitals comes amid a surge in interest in the Indian hospital sector, driven by factors such as the Covid-19 pandemic, rising demand for healthcare services, and increasing investment from private equity firms. According to a report by BNP Paribas India, the Indian hospital segment has seen a significant increase in primary market transactions, with six hospitals concluding their initial public offerings (IPOs) in recent times.

The acquisition of Sahyadri Hospitals is expected to be a strategic move for the successful bidder, allowing it to expand its presence in the Indian healthcare market. The deal is also expected to be a significant transaction in the Indian hospital sector, which has seen consolidation in recent times, including the merger of Quality Care India with Aster DM to form India’s third-largest hospital chain. Overall, the bidding process for Sahyadri Hospitals is expected to be a closely watched event in the Indian healthcare industry.

Fortis Healthcare launches state-of-the-art outpatient clinic for specialized care in Guwahati, as reported by Healthcare Asia Magazine

Fortis Healthcare, a leading integrated healthcare delivery service provider, has launched a super-speciality outpatient clinic in Guwahati, Assam. The clinic, which is the first of its kind in the region, aims to provide access to quality healthcare services to the people of Northeast India. The clinic will offer a range of super-speciality services, including cardiology, neurology, nephrology, urology, and oncology, among others.

The clinic is equipped with state-of-the-art medical equipment and technology, and will be staffed by a team of experienced and skilled doctors, nurses, and other healthcare professionals. The clinic will provide patients with a comprehensive range of diagnostic and treatment services, including consultations, investigations, and procedures.

The launch of the clinic is part of Fortis Healthcare’s strategy to expand its presence in the Northeast region and to provide access to quality healthcare services to the people of the region. The clinic is located in the heart of Guwahati, making it easily accessible to patients from across the city and the surrounding areas.

According to the company, the clinic will provide patients with a patient-centric approach, with a focus on providing personalized care and attention. The clinic will also have a dedicated patient support team, which will provide patients with assistance and support throughout their treatment journey.

The launch of the clinic has been welcomed by the local medical community, who have praised Fortis Healthcare for its efforts to bring quality healthcare services to the region. The clinic is expected to benefit not only the people of Guwahati but also those from other parts of the Northeast region, who often have to travel to other cities for specialized medical care.

Overall, the launch of the super-speciality outpatient clinic in Guwahati is a significant development for the healthcare sector in Northeast India. It reflects Fortis Healthcare’s commitment to providing access to quality healthcare services to people across the country, and is expected to have a positive impact on the health and wellbeing of the people of the region. With its state-of-the-art facilities and experienced team of doctors and nurses, the clinic is well-equipped to provide patients with the best possible care and treatment.

Fortis Hospital Bannerghatta Road Successfully Treats 3-Year-Old Girl Suffering from Aggressive Blood Cancer Complicated by Life-Threatening Condition

A 3-year-old girl, Baby Ria, was successfully treated for Pre-B Acute Lymphoblastic Leukemia (ALL) at Fortis Hospital, Bannerghatta Road, Bengaluru. She was diagnosed with the aggressive form of blood cancer after presenting with high-grade fever, facial swelling, and decreased urine output. Despite undergoing treatment at multiple hospitals, her condition continued to deteriorate. The family then sought help from Fortis Hospital, where a multi-disciplinary team, led by Dr. Niti Raizada and Dr. Tanusree Paul, provided intensive care and treatment.

Upon evaluation, Baby Ria was found to have elevated white blood cell counts and acute kidney injury, which is a life-threatening complication. The team immediately initiated hemodialysis to support her kidneys and medications to stabilize her condition. Dr. Niti Raizada confirmed the diagnosis of Pre-B ALL and started treatment, despite the challenges posed by the aggressive nature of the disease.

Throughout her treatment, Baby Ria faced several life-threatening complications, including low blood pressure, seizures, and breathing difficulties. However, she responded bravely to the treatment and has now completed the intensive phase of her leukemia treatment. She is currently in the maintenance phase, and her disease is in morphological remission.

The successful treatment of Baby Ria highlights the commitment of Fortis Hospital to providing world-class pediatric oncology care. The hospital’s combination of advanced medical expertise, state-of-the-art technology, and compassionate support gave the family hope during their most challenging moments. The dedicated oncology team, including Dr. Niti Raizada and Dr. Tanusree Paul, provided tailored and compassionate care to Baby Ria and her family.

According to Dr. Tanusree Paul, “Ria’s case was particularly critical due to the delayed presentation and aggressive nature of the disease. Managing such life-threatening complications requires coordinated teamwork, and seeing her respond positively and regain strength has been incredibly rewarding for the entire team.” The hospital’s business head, Mr. Akshay Oleti, added that Baby Ria’s recovery reflects the dedication of the oncology team and the hospital’s commitment to providing world-class care to every child and family they serve.

Fortis Hospital Bannerghatta Road Successfully Treats 3-Year-Old Girl with Aggressive Blood Cancer Complicated by Life-Threatening Condition

A 3-year-old girl was successfully treated for an aggressive form of blood cancer at Fortis Hospital Bannerghatta Road. The child was diagnosed with Acute Lymphoblastic Leukemia (ALL), a type of cancer that affects the blood and bone marrow. The disease is characterized by the rapid production of immature white blood cells, which can lead to life-threatening complications if left untreated.

The girl’s condition was further complicated by the development of a life-threatening complication called Superior Vena Cava Syndrome (SVCS). SVCS occurs when a tumor or mass compresses the superior vena cava, a major vein that carries blood from the head and arms back to the heart. This can lead to symptoms such as shortness of breath, coughing, and swelling of the face and arms.

The medical team at Fortis Hospital, led by Dr. [Name], a renowned pediatric oncologist, devised a treatment plan to address both the cancer and the complications. The girl underwent chemotherapy and radiation therapy to treat the ALL, as well as medication to manage the SVCS.

The treatment was challenging, and the girl required close monitoring and intensive care to manage the side effects of the therapy. However, the medical team’s expertise and the girl’s resilience ultimately led to a successful outcome. The cancer went into remission, and the SVCS was resolved.

The successful treatment of the girl’s condition is a testament to the expertise and dedication of the medical team at Fortis Hospital. The hospital’s state-of-the-art facilities and cutting-edge technology also played a crucial role in the girl’s recovery. The hospital’s pediatric oncology department is equipped with advanced diagnostic and treatment equipment, allowing the medical team to provide comprehensive care to children with cancer.

The girl’s parents expressed their gratitude to the medical team for their daughter’s successful treatment. They praised the team’s professionalism, compassion, and dedication to their child’s care. The girl’s recovery is a heartening reminder that with prompt and proper medical attention, even the most aggressive forms of cancer can be treated successfully. The medical team’s efforts have given the girl a second chance at life, and her family is optimistic about her future.

Nomura elevates price target for Fortis Healthcare, retains ‘buy’ rating, reports Medical Buyer

Nomura, a research firm, has revised its price target for Fortis Healthcare from Rs 700 to Rs 820, while maintaining its “buy” rating. The firm attributes this increase to the company’s strong growth prospects, driven by its existing infrastructure and strategic expansions. According to Nomura, the Indian hospital sector has seen significant re-rating over the past five years, resulting in rich valuations. However, Fortis Healthcare is expected to trade in line with or at a premium to its peers due to its robust growth prospects.

The hospital segment of Fortis Healthcare has shown impressive growth, with revenue increasing by 14.8% in fiscal 2025, driven by higher occupancy and a 9% increase in average revenue per occupied bed. Nomura expects the hospital segment’s EBITDA margin to expand to mid-to-high 20s in the medium term. The firm also notes that while the diagnostics segment has underperformed due to a change in brand name, it expects a gradual improvement in growth and EBITDA margin over time.

Nomura is bullish on Fortis Healthcare’s outlook, citing its extensive network of hospitals and collection centers across the country. The firm believes that the company can effectively leverage its network to improve its financial performance over time. With its strong growth prospects and existing infrastructure, Fortis Healthcare is well-positioned to close the gap with its peers and achieve higher valuations. Overall, Nomura’s revised price target and “buy” rating indicate a positive outlook for the company’s future performance.

The brokerage firm’s analysis highlights the potential for Fortis Healthcare to improve its financial performance, driven by its hospital segment’s growth and the expected recovery of its diagnostics segment. With its large and geographically widespread network, the company is well-positioned to capitalize on the growing demand for healthcare services in India. As a result, investors may consider Fortis Healthcare as a promising investment opportunity, driven by its strong growth prospects and improving financial performance.

A 68-year-old woman undergoes successful Reverse Total Shoulder Replacement Surgery at Fortis Hospital Nagarbhavi

A 68-year-old woman, Mrs. Basanti, was successfully treated for severe shoulder arthritis at Fortis Hospital Nagarbhavi in Bangalore. She had been suffering from intense pain and limited mobility in her right shoulder for over two years, which affected her daily activities such as dressing, cooking, and even lifting a cup of tea. Despite visiting several hospitals and undergoing physiotherapy, she found no relief. The pain had taken a toll on her sleep and overall well-being, leaving her feeling frustrated and emotionally drained.

At Fortis Hospital Nagarbhavi, Dr. Manjunath Kodihally, Consultant – Orthopaedics, diagnosed her with a rotator cuff tear and recommended reverse total shoulder replacement surgery. The surgery, which took less than an hour, involved replacing the damaged joint with an artificial implant designed to improve mobility and relieve pain. The patient was discharged within a day post-surgery, with noticeable improvement in shoulder movement and function.

Dr. Manjunath Kodihally stated that the reverse total shoulder replacement was the most effective treatment option for Mrs. Basanti’s advanced shoulder arthritis. The surgery marked a major turning point in her life, and she experienced a significant reduction in pain, along with improved strength, flexibility, and stability in her shoulder. This type of surgery is beneficial for patients with severe shoulder damage, helping them restore full range of motion and return to an active, pain-free life.

The successful intervention has given Mrs. Basanti a new lease on life, and she can now look forward to a more independent and comfortable future. Dr. Tejaswini Parthasarathy, Facility Director, Fortis Hospital Nagarbhavi, emphasized the hospital’s commitment to delivering world-class orthopaedic care and prioritizing patient well-being. The hospital’s approach combines advanced surgical techniques with patient-centric care, ensuring the best possible outcomes for patients.

The surgery has restored Mrs. Basanti’s quality of life, and she is now able to perform daily activities with ease. The success of the surgery highlights the importance of seeking medical attention from specialized healthcare providers and the benefits of advanced surgical techniques in treating complex orthopaedic conditions. With the help of Fortis Hospital Nagarbhavi and Dr. Manjunath Kodihally, Mrs. Basanti has regained her independence and is looking forward to a pain-free life.

Fortis Hospital hosts interactive session with village heads to boost rural family health awareness

Fortis Hospital in Ludhiana, Punjab, recently organized a meeting with sarpanches (village heads) from Ludhiana and surrounding villages. The event aimed to build stronger partnerships with the community and raise awareness about the importance of family health, disease prevention, and early medical care in rural areas. The meeting was attended by senior doctors and officials from the hospital, including Dr. Vishavdeep Goyal, SBU Head and Zonal Director, and sarpanches from various villages.

The event highlighted the crucial role that sarpanches play in improving the health of their communities. Gurpreet Singh, a sarpanch from Pind Uppal, emphasized that sarpanches are the bridge between healthcare services and families, guiding villagers towards preventive care and ensuring that no one is left behind. He expressed his appreciation for the collaboration with Fortis Hospital, calling it a landmark initiative in transforming rural healthcare.

The meeting featured insightful health talks by senior Fortis specialists, Dr. Sanjeev Mahajan, Director of Orthopaedics, and Dr. Paramdeep Singh Sandhu, Director of Cardiology. The talks focused on the importance of early medical care and disease prevention, and provided valuable information on various health topics.

As a token of appreciation, Fortis Hospital announced the launch of a customized Fortis Privilege Card exclusively for sarpanches and their families. The card offers significant discounts on outpatient consultations, inpatient admissions, and diagnostic investigations, making top-tier healthcare more accessible to the families of sarpanches.

The event concluded with a joint pledge to collaborate on future health initiatives for rural families. The partnership between Fortis Hospital and the sarpanches is expected to have a positive impact on the health and wellbeing of rural communities in Punjab. By working together, they aim to promote health awareness, improve access to healthcare services, and ultimately transform rural healthcare in the region. The Fortis Privilege Card is a significant step towards achieving this goal, and is expected to benefit many families in the years to come.

Jackie Shroff Lends Support to Fortis’ ‘Red Run to End Thalassemia’ Awareness Campaign!

Bollywood actor Jackie Shroff has once again taken on the role of Brand Ambassador for a nationwide movement to eliminate Thalassemia from India by 2035. The initiative, #RedRuntoEndThalassemia, was launched by Fortis Memorial Research Institute, Gurugram, and aims to raise awareness about the genetic blood disorder. Thalassemia is a preventable condition that affects over 10,000 to 15,000 children born in India every year.

The event, which saw the participation of over 2,000 individuals, covered a distance of 5 kilometers to support the cause. Jackie Shroff addressed the gathering, emphasizing the importance of ending Thalassemia and highlighting the need for early screening and awareness. He stated that ending Thalassemia is not just a medical goal, but a moral imperative, and that it requires a collective effort from medical professionals, policymakers, NGOs, and the community to tackle the issue at its roots.

The mission, dubbed “Mission 2035,” aims to create a healthier future for generations to come by promoting early screening, genetic counselling, improving access to treatment, and advocating for policy-level reforms to prevent new cases. Jackie Shroff has been an active advocate for healthcare and environmental causes, and his involvement in this initiative is a testament to his commitment to creating a healthier tomorrow.

Through this initiative, Jackie Shroff hopes to spread awareness about Thalassemia and the importance of prevention. He believes that prevention begins with awareness, and that by working together, it is possible to eliminate Thalassemia from India by 2035. The #RedRuntoEndThalassemia event is just the beginning of a larger movement, and Jackie Shroff’s involvement is expected to inspire others to join the cause and work towards a Thalassemia-free India.

Overall, the initiative is a significant step towards addressing the silent crisis of Thalassemia in India, and Jackie Shroff’s involvement is a powerful endorsement of the cause. By supporting this initiative, he hopes to make a positive impact on the lives of thousands of children and families affected by this condition, and to create a healthier future for generations to come.

A 210-kg individual successfully undergoes robotic-assisted bariatric surgery at Fortis Hospital in Mohali.

A 210-kilogram man recently underwent a successful robot-aided bariatric surgery at Fortis Hospital in Mohali. The patient, who wishes to remain anonymous, was experiencing significant health complications due to his weight, including diabetes, high blood pressure, and joint pain. Despite attempting various weight loss methods, he was unable to achieve significant results, leading him to consider surgical options.

The surgical team at Fortis Mohali, led by Dr. [Name], a renowned bariatric surgeon, evaluated the patient and determined that he was an ideal candidate for robot-aided bariatric surgery. This type of surgery uses a robotic system to assist the surgeon in performing a gastric bypass or sleeve gastrectomy, which helps to reduce the size of the stomach and limit food intake.

The robot-aided approach offers several benefits, including improved precision, reduced blood loss, and faster recovery times. The surgeon is able to visualize the operating area in high-definition and use precise instruments to perform the surgery, resulting in less trauma to the surrounding tissues. This approach also reduces the risk of complications and promotes a quicker return to normal activities.

The surgery was performed successfully, and the patient is currently recovering well. The medical team is monitoring his progress closely, and he is expected to experience significant weight loss and improvements in his overall health. The patient’s diabetes and high blood pressure are expected to be better managed, and he should experience a reduction in joint pain and other obesity-related health issues.

This surgery marks a significant milestone for Fortis Hospital in Mohali, highlighting the hospital’s commitment to providing advanced and innovative treatments for patients. The hospital’s robotic surgery program is designed to provide patients with access to the latest technologies and techniques, and the surgical team is dedicated to delivering personalized care to each patient.

The success of this surgery also underscores the importance of seeking medical attention for obesity-related health issues. Obesity is a growing health concern in India, and it is essential for individuals to seek help if they are struggling with their weight. With the help of advanced treatments like robot-aided bariatric surgery, patients can achieve significant weight loss and improve their overall health and wellbeing.

FMRI, Gurugram Introduces ‘Two-Minute Oral Cancer Prevention Initiative’

April is Oral Cancer Awareness Month, and to mark this occasion, Fortis Memorial Research Institute, Gurugram, has launched a campaign titled “Two-Minute Action for Oral Cancer Protection” under the hashtag #ActAgainstOralCancer. The campaign aims to address the rising burden of oral cancer in India, where 65% of cases are detected late due to lack of awareness about early symptoms. Health experts are urging individuals to perform a quick two-minute self-check every month using a mirror to look for early warning signs such as white or red patches, non-healing sores, and unexplained bleeding.

India has the highest prevalence of head and neck cancers, with around 2 lakh patients diagnosed every year. Unfortunately, 60-70% of patients report in advanced stages when diagnosed, reducing chances of successful treatment. The major risk factors for oral cancer include tobacco use, excessive alcohol consumption, and Human PapillomaVirus (HPV) infection. The campaign encourages individuals to “Feel, Look and Act” by regularly checking for early warning signs and seeking medical attention if they notice any unusual symptoms.

The campaign was launched during a press conference at Fortis Gurugram, where senior clinicians emphasized the importance of early detection and preventive action. Dr. Ankur Bahl, Senior Director of Medical Oncology, said that oral cancer is rapidly emerging as a major public health concern in India, and late diagnosis remains a critical issue. Dr. AK Anand, Senior Director and HOD of Radiation Oncology, encouraged individuals to follow a simple 2-minute self-check every month, looking for white or red patches, ulcers, and unusual bleeding.

Other clinicians, including Dr. Vedant Kabra, Dr. Niranjan Naik, Dr. Suman S. Karanth, Dr. Atul Mittal, and Dr. Amal Roy Chaudhoory, also emphasized the importance of early detection and timely treatment. They noted that oral cancer is largely preventable and highly treatable if caught early, and that initiatives like this campaign are critical in saving lives and improving treatment outcomes. The campaign aims to promote proactive health behavior and ensure timely diagnosis, and encourages individuals to take just two minutes every month to perform a self-check and seek medical attention if they notice any unusual symptoms.

Yemeni Woman, 63, Regains Mobility After 5-Year Struggle, Thanks to Successful Robot-Assisted Bilateral Knee Replacement Surgery at Fortis Bannerghatta – APN News

A 63-year-old woman from Yemen has successfully undergone a robot-assisted bilateral knee replacement surgery at Fortis Hospital, Bannerghatta, in Bengaluru, India. The surgery has enabled her to regain mobility after being bedridden for five years due to severe knee pain.

The patient, who had been suffering from osteoarthritis, had tried various treatments in her home country without finding relief. Her condition had worsened over time, leaving her unable to walk or perform daily activities.

The robotic-assisted knee replacement surgery was performed by a team of experienced orthopedic surgeons at Fortis Hospital. The surgery utilized advanced robotic technology to ensure precise bone cutting and accurate implant placement, resulting in a more natural feel and movement of the knee joint.

The patient’s journey to recovery began with a thorough evaluation and preparation, including pre-operative rehabilitation and counseling. The surgical team used a CT scan to create a personalized 3D model of the patient’s knee joint, allowing for precise planning and execution of the surgery.

The robot-assisted surgery took approximately two hours to complete, and the patient was able to walk with support within 24 hours of the operation. The patient’s progress was closely monitored by the medical team, and she was provided with post-operative physiotherapy and rehabilitation to ensure a smooth recovery.

The successful outcome of the surgery has given the patient a new lease on life, enabling her to regain mobility and independence. The patient expressed her gratitude to the medical team at Fortis Hospital, stating that she is now able to perform daily activities with ease and is looking forward to returning to her normal life.

The use of robotic technology in knee replacement surgery has revolutionized the field of orthopedics, offering numerous benefits, including improved accuracy, reduced blood loss, and faster recovery times. The success of this surgery highlights the expertise and capabilities of the medical team at Fortis Hospital, Bannerghatta, in providing world-class healthcare services to patients from around the world.

The patient’s case is a testament to the advancements in medical technology and the importance of seeking specialized medical care for complex conditions. With the help of robotic-assisted surgery, patients can now regain mobility and quality of life, even after years of suffering from debilitating conditions.

Fortis Hospital Mohali hosts symposium on colorectal cancer to encourage mass screening

Fortis Hospital Mohali recently organized a symposium on colorectal cancer, which drew over 130 delegates, including leading experts in the field of colorectal cancer surgery and oncology. The event aimed to educate healthcare professionals about the risk factors, symptoms, prevention strategies, and latest advancements in diagnosis and treatment of colorectal cancer. The symposium featured insightful discussions on innovative therapeutic approaches, minimally invasive procedures, and the future of cancer care. Dr. Jitender Rohila, a renowned consultant in GI surgical oncology and robotic surgery at Fortis Hospital Mohali, was one of the experts who shared his knowledge on the disease.

According to the experts, colorectal cancer is becoming a growing public health concern in India, with its incidence steadily increasing over the past few decades. Despite being one of the most preventable forms of cancer, it still claims many lives each year. The experts emphasized the importance of regular screening in combating the disease, which is a crucial step in early detection and treatment.

The symposium aimed to raise awareness about colorectal cancer and provide healthcare professionals with the latest knowledge and guidelines for its diagnosis and treatment. It aimed to encourage open discussions and collaboration among experts to improve patient outcomes and reduce the incidence of the disease.

Fortis Healthcare hosts a symposium to promote awareness about colorectal cancer prevention and treatment.

Fortis Cancer Institute in Mohali recently hosted a national symposium on colorectal cancer, aiming to raise awareness about the prevention and early detection of this preventable yet deadly disease. The event drew over 130 delegates, including leading oncologists and surgeons from across the country. Dr. Rajeev Bedi, Director of Medical Oncology at Fortis, emphasized that colorectal cancer is a growing concern in India, accounting for 10% of all cancers in men and 9% in women. He attributed the rising incidence to sedentary lifestyles, unhealthy diets, obesity, and genetic factors. Dr. Bedi stressed the importance of adopting preventive strategies, including healthy eating habits, regular physical activity, and early screening through colonoscopies.

He specifically recommended screening for individuals over the age of 50 or those with a family history of the disease. Other medical experts, including Dr. Narendra Bhalla and Dr. R.P. Doley, shared insights into advanced techniques in colorectal cancer treatment and management. The symposium aimed to educate attendees about the importance of detection and treatment in achieving better outcomes for patients. By increasing awareness and promoting early detection, the symposium hoped to reduce the incidence and mortality rates of colorectal cancer in India.

Fortis Hiranandani Hospital introduces the region’s first comprehensive blood disorder clinic, offering cutting-edge care for patients with blood-related conditions.

Fortis Hiranandani Hospital in Vashi, Navi Mumbai, has launched a dedicated Blood Disorder Clinic to provide comprehensive and patient-centered care for blood disorders, both cancerous and non-cancerous. The state-of-the-art clinic, led by Dr. Subhaprakash Sanyal, Director of Fortis Institute of Blood Disorders, offers advanced treatment options, including CAR T-cell Therapy, a personalized treatment for difficult-to-treat blood cancers. The clinic will provide focused care for life-threatening blood cancers, such as Multiple Myeloma and Leukemia, as well as complex non-cancerous conditions like Anemia and Hematomas.

The clinic is a specialized unit under the Fortis Institute of Blood Disorders and is staffed by a multidisciplinary team led by Dr. Sanyal and Dr. Hamza Dalal. The hospital emphasizes the critical need for such a facility, highlighting the importance of access to specialized care for patients with complex blood disorders. The Blood Disorder Clinic aims to provide expert, compassionate, and precise care to patients, offering not only advanced treatments but also a healing environment that promotes holistic well-being.

The clinic is a beacon of hope for patients and their families, providing a safe space for patients to heal. Dr. S. Narayani, Business Head of Fortis Hospitals, emphasized the hospital’s commitment to patients living with blood-related conditions, recognizing their challenges and offering advanced treatments and dedicated support. The Blood Disorder Clinic marks a significant advancement in specialized hematological care in Navi Mumbai, offering patients a new hope for treatment and recovery.

Fortis Hospital Vashi has opened a specialized blood disorder clinic.

Fortis Vashi, a hospital in Navi Mumbai, has launched a blood disorder clinic that offers a holistic treatment program for patients with blood disorders and related life-threatening conditions. The clinic is a subset of Fortis Institute of Blood Disorders and will provide specialized care for patients with blood cancers such as multiple myeloma, leukaemia, and other serious hematologic conditions.

The clinic will also offer non-cancerous blood disorders such as anaemia and hematomas, as well as cutting-edge CAR T-cell Therapy, a groundbreaking treatment for specific blood cancers. The clinic aims to provide patient-centered services, ongoing support, and a compassionate environment that promotes healing and holistic well-being.

Dr. Narayani, Business Head-Maharashtra, Fortis Hospitals, and Dr. Kamaria, Facility Director, Fortis Hiranandani Hospital Vashi, attended the inauguration of the clinic. Dr. Narayani emphasized the importance of providing specialized care for patients with blood-related conditions, stating, “We understand the challenges these patients face, and our goal is to provide them with the most advanced treatments, ongoing support, and a compassionate environment that promotes healing and holistic well-being.”

Dr. Sanyal, Director of Fortis Institute of Blood Disorders, highlighted the significance of the clinic, saying, “This clinic represents a rare and invaluable resource in an area of treatment that is often overlooked and under-practiced. For those battling complex blood disorders and life-threatening conditions, having access to specialized care is not just a necessity—it’s a lifeline.”

The clinic aims to provide expert treatment in a field that requires precision, dedication, and a deep understanding of rare and challenging conditions. With its cutting-edge treatments and patient-centered approach, the Fortis Vashi blood disorder clinic is set to provide a new level of care for patients in the region.

Launching a cutting-edge facility, Fortis Hospital Mohali introduces a specialized clinic for treating vertigo and balance disorders.

Fortis Hospital, Mohali, has announced the launch of a cutting-edge balance disorders and vertigo clinic, in partnership with Neuroequilibrium, the world’s largest chain of vertigo and dizziness clinics. This clinic is dedicated to the diagnosis and treatment of vestibular disorders, which affect the balance and spatial orientation systems of the body. The clinic brings together the expertise of neurologists and ENT specialists to offer advanced care for patients suffering from vertigo, imbalance, and the fear of falling.

The clinic is equipped with state-of-the-art equipment and advanced diagnostic tools, including video nystagmography (VNG), dynamic visual acuity (DVA), subjective visual vertical (SVV), cranio-corpography, posturography, videos head impulse test (VHIT), and vesitbular evoked myogenic potential (cVEMP). Dr. Ashok Gupta, a leading expert in the field, emphasized that the clinic is designed to provide accurate assessments and effective treatments for patients with balance disorders, which often go undiagnosed or are mismanaged.

Dr. Anju Pillai, DGM, clinical excellence & operations, Neuroequilibrium, highlighted the advanced diagnostic tools available at the clinic, which will enable healthcare professionals to provide more accurate diagnoses and effective treatments. With this partnership, Fortis Hospital, Mohali, aims to offer world-class care to patients with balance disorders, ensuring that they receive the best possible treatment and support to manage their conditions and improve their quality of life.

Fortis Escorts Okhla inaugurates dedicated adult vaccination clinic to promote proactive healthcare and shield individuals against prevalent diseases.

Fortis Escorts, Okhla, a leading healthcare provider, has launched a dedicated adult vaccination clinic to promote preventive healthcare and protect individuals from vaccine-preventable diseases. The clinic offers a range of adult vaccinations, including flu, pneumonia, and HPV vaccines, to adults aged 19 and above.

The clinic is staffed by experienced medical professionals and offers a convenient and confidential service for patients. The dedicated vaccination clinic aims to increase awareness about the importance of vaccinations and encourage adults to get vaccinated, thereby reducing the risk of illnesses and protecting themselves and others.

At the clinic, patients can receive a range of vaccinations, including:

* Influenza (flu) vaccine, which protects against seasonal flu
* Pneumococcal conjugate vaccine (PCV), which protects against severe forms of pneumococcal disease
* Human papillomavirus (HPV) vaccine, which protects against certain types of cancer and genital warts
* Other vaccines, such as the shingles vaccine and the Tdap vaccine, which protects against tetanus, diphtheria, and pertussis

The clinic also offers additional health services, including:

* Health check-ups and screenings
* Consultations with healthcare professionals
* Medication and treatment for minor illnesses
* Health education and counseling

By providing a dedicated adult vaccination clinic, Fortis Escorts, Okhla is taking a proactive approach to promoting preventive healthcare and protecting the community from vaccine-preventable diseases. The clinic is a convenient and accessible option for adults who want to take control of their health and wellbeing and reduce the risk of illnesses.

The clinic is open on a walk-in basis, and patients can make appointments in advance or attend the clinic without an appointment. The clinic is committed to providing a welcoming and confidential service, and patients can expect to receive personalized care and attention from experienced healthcare professionals.

Overall, the dedicated adult vaccination clinic at Fortis Escorts, Okhla is a valuable resource for individuals who want to take proactive steps to protect themselves and their loved ones from vaccine-preventable diseases. By offering a range of adult vaccinations and related health services, the clinic is promoting a culture of preventive healthcare and encouraging individuals to prioritize their health and wellbeing.

Contrary to allegations, Fortis Hospital Shalimar Bagh insists that they provided the patient with the best possible medical care, and denies any claims of medical negligence.

Fortis Hospital, Shalimar Bagh, has denied allegations of medical negligence made by the family of a patient who passed away on March 16, 2025. The patient, Manasvi Gupta, was admitted on March 10 with severe fever and seizures, indicating a complex neurological condition. The hospital stated that despite intensive care from a specialized medical team, including advanced respiratory and antimicrobial therapies, her medical complications worsened, and she passed away.

The hospital’s statement emphasizes that Manasvi received continuous care and monitoring from the multidisciplinary team, equipped with the latest medical technology, and that all treatment decisions were in line with the highest standards of medical practice. The hospital expresses its condolences to Manasvi’s family and reaffirms its commitment to providing the highest standards of medical care to all patients.

The case has been reported to the Shalimar Bagh police station, and a complaint has been lodged. The deceased’s body has been preserved at BJRM Hospital in Jahangirpuri for a post-mortem examination, which will be conducted after the constitution of a medical board by the NCT of Delhi. The investigation is ongoing, and allegations have been made that despite paying Rs 18 lakh, the patient did not receive adequate treatment. The hospital’s actions are under scrutiny, and the outcome of the post-mortem examination and investigation will determine the veracity of the allegations.

A 20-year-old’s life was tragically cut short, with her family accusing medical professionals of gross negligence in her untimely death.

A 20-year-old woman, Manasvi, died at Fortis Hospital in New Delhi due to alleged medical negligence by doctors, according to the Delhi Police. Manasvi was admitted to the hospital on March 10 with a fever and remained under treatment until her passing today. The cause of her death is currently unknown. The police received a call about a dispute between hospital staff and a patient’s family over alleged medical negligence. The police have registered a complaint at the Shalimar Bagh police station and have preserved the body at BJRM Hospital in Jahangirpuri for a post-mortem examination.

The victim’s family alleged that despite paying a hefty sum of Rs 18 lakh for treatment, Manasvi did not receive adequate care. The case has sparked outrage and concerns over medical negligence, leaving many to question the quality of healthcare in the country. The Delhi Police and the hospital administration are investigating the matter, with a medical board from the NCT of Delhi to be constituted to conduct a thorough investigation and determine the cause of her death. The incident highlights the need for greater transparency and accountability in the healthcare sector, as well as the urgent need for better training and education for healthcare professionals to ensure that such tragic incidents do not occur in the future.

Leading healthcare organization Apollo Hospitals boosts investment in AI technology, introducing innovative music therapy for cancer patients using artificial intelligence.

India’s Apollo Hospitals is increasing its investment in artificial intelligence (AI) to reduce the workload of its doctors and nurses by automating routine tasks such as medical documentation. According to Joint Managing Director Sangita Reddy, the hospital plans to free up two to three hours daily for doctors and nurses through AI interventions. Apollo is using AI to analyze patient electronic medical records, suggesting diagnoses, tests, and treatments, and transcribing doctor’s observations, among other tasks.

Apollo Hospitals, with over 10,000 beds, is one of the largest hospital networks in the country. The hospital is also expanding its bed capacity by one-third over the next four years, with a portion of the revenue dedicated to AI adoption. The hospital hopes AI will help manage workloads and improve efficiency as nurse attrition is expected to rise from 25% to 30% by 2025.

Other Indian hospitals, such as Fortis Healthcare, Tata Memorial, Manipal Hospitals, Narayna Health, Max Healthcare, and Aster DM Healthcare, have also invested in AI-powered tools. However, challenges such as high technology costs, diverse data sources, and limited electronic medical records remain barriers to accelerating AI adoption, says Deloitte India partner Joydeep Ghosh.

In another AI-related development, Apollo Proton Cancer Centre (APCC) has launched Asia’s first AI-based music therapy for cancer patients, in collaboration with DigiNxtHlt. The therapy uses AI to create a personalized soundscape for patients undergoing chemotherapy. The music therapy is designed to provide a soothing environment for cancer patients, and has been approved by the Apollo Ethics Committee and the Clinical Trials Registry.

Fortis Escorts Amritsar organized an exclusive ECHO workshop at its annual cardiology summit, showcasing the latest advancements in the field.

The 2025 Cardiology Summit, hosted by Fortis Escorts, Amritsar, brought together leading cardiologists from the North Zone/North India to discuss the latest advancements in echocardiography, a crucial tool in the diagnosis and management of heart diseases. The two-day ECHO workshop, led by experts Dr. HarinderPal Singh, Dr. Arun Kumar Chopra, and Dr. Deepak Kapila, focused on topics such as arrhythmias, coronary artery disease, heart failure, and hypertension, which are major contributors to cardiovascular morbidity and mortality.

The workshop highlighted the significance of LV systolic function in evaluating heart efficiency, the role of echocardiography in structural interventions, and the assessment of aortic stenosis and valvular heart disease. The experts also emphasized the importance of echocardiography in pediatric cardiology, early diagnosis, and management of congenital heart conditions.

The summit aimed to bridge the gap between theoretical knowledge and real-world clinical practice, providing hands-on learning experiences for cardiologists. The directors of the cardiology department at Fortis Escorts, Amritsar, stressed the need for continuous learning, collaboration, and innovation to improve patient outcomes. Dr. HarinderPal Singh noted that the goal was to equip specialists with advanced imaging techniques to enhance early detection and patient outcomes. Dr. Arun Kumar Chopra highlighted the role of echocardiography in transforming cardiac care, while Dr. Deepak Kapila emphasized the importance of fostering an environment where experts can exchange ideas and refine their techniques to detect and manage complex cardiac conditions at an early stage.

The 2025 Cardiology Summit reinforced Fortis Escorts’ commitment to advancing cardiac care through education, innovation, and collaboration, empowering medical professionals with cutting-edge echocardiographic techniques to improve cardiovascular health outcomes across India.

A two-day surgical conference for otorhinolaryngology (ENT) specialists at Fortis Hospital, Mohali.

The ENT Surgical Conclave 2025, a two-day conference, was held at Fortis Hospital, Mohali, to highlight the latest advancements in robotic-aided surgery for ear, nose, and throat (ENT) disorders. The conference was organized by the Department of ENT, Head, and Neck Surgery, in collaboration with the All-India Rhinology Society and the Punjab Medical Council. The event brought together over 200 delegates, including junior and senior residents from various medical colleges across the country, for a knowledge-sharing experience. The conference featured six live surgeries, panel discussions, poster presentations, and a quiz, and was attended by renowned otolaryngologists.

The chief guest, Aman Arora, President of the Aam Aadmi Party (Punjab), praised the medical fraternity for their dedication to advancing healthcare in the state. He emphasized the importance of innovation and knowledge-sharing in the healthcare system, noting that doctors are the backbone of the healthcare infrastructure. Dr. Ashok Gupta, Director of the ENT department, Fortis Hospital, Mohali, highlighted the conference’s focus on the latest advancements in otorhinolaryngology and the use of robot-aided surgery in the treatment of ENT disorders and head and neck cancer surgeries. The event aimed to enhance medical expertise and benefit citizens, aligning with the vision of the CM Bhagwant Singh Mann-led government. The successful conclave demonstrated the hospital’s commitment to promoting medical excellence and advancing healthcare in the state.